Back to search

Article

Electrolyte disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

2024-08-30

Abstract excerpt

<h4>Background: </h4> Life functions depend on electrolytes. Life-threatening complications can occur when electrolyte disorders disrupt normal bodily functions. Recent reports have linked immune checkpoint inhibitors (ICIs) with electrolyte disorders. Due to this, ICIs need to be evaluated for their impact on electrolyte balance. <h4>Methods: </h4>: In this study, adverse reaction reports for ICIs were analyzed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2925659f-535f-55af-9634-e7c18fa50756
DOI
10.22541/au.172499172.21625269/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Electrolyte disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) databaseDOI 10.22541/au.172499172.21625269/v1
Electrolyte Disorders Induced by Multikinase Inhibitors Therapy for Renal Cell Carcinoma：A Large-Scale Pharmacovigilance AnalysisSemantic proximity
Adverse Event Profiles of CDK4/6 inhibitors: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) databaseSemantic proximity
Hepatic Failure Associated with Immune Checkpoint Inhibitors: A Real-world Study from the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseSemantic proximity
Clinical Characteristics and Human Leukocyte Antigens in patients with Immune Checkpoint Inhibitor-induced Type 1 Diabetes and Pituitary Dysfunction: A single center prospective studySemantic proximity
Thyroid-related Adverse Events Caused by Immune Checkpoint Inhibitors Associated with Therapeutic Outcomes in Cancer Patients: a systematic review and meta-analysisSemantic proximity
Insights Into the Host Contribution of Endocrine Associated Immune-Related Adverse Events to Immune Checkpoint Inhibition TherapySemantic proximity
PD-1/PD-L1 Inhibitor-Related Cystitis: Clinical Features, Diagnostic Exclusion, and Outcomes in an Eight-Patient Case Series with a Targeted Literature ReviewSemantic proximity
Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: A retrospective studySemantic proximity
Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral NeuropathySemantic proximity
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for OsimertinibSemantic proximity
Adverse event profile differences between Trastuzumab Emtansine and Trastuzumab Deruxtecan: a real-world, pharmacovigilance studySemantic proximity
Real-world pharmacovigilance study of voclosporin based on FAERS and VigiBaseSemantic proximity
Select a neighboring publication to make it the new centre.